MedSun: E-mail This Item To a Friend

E-mail This Item To a Friend

Sending the item "Early Communication About an Ongoing Safety Review of Tumor Necrosis Factor (TNF) Blockers (marketed as Remicade, Enbrel, Humira, and Cimzia)" to a friend.

NOTE: This item will be sent from the e-mail address medsun@cdrh.fda.gov. Your email address will be noted in the body of the message. Some mailing lists restrict submissions to previously cleared email addresses. If you want to forward this item to a mailing list, you may want to first send the item to yourself and then forward the message from your email account.